These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [A case of systemic lupus erythematosus diagnosed 7 years after epileptic seizure and developed chorea during prednisolone treatment]. Wakasugi M; Sato T; Maruyama Y; Ueno M; Arakawa M Ryumachi; 1996 Jun; 36(3):545-50. PubMed ID: 8779791 [TBL] [Abstract][Full Text] [Related]
5. Epilepsy with myoclonic absences: Electroclinical characteristics in a distinctive pediatric epilepsy phenotype. Zanzmera P; Menon RN; Karkare K; Soni H; Jagtap S; Radhakrishnan A Epilepsy Behav; 2016 Nov; 64(Pt A):242-247. PubMed ID: 27770719 [TBL] [Abstract][Full Text] [Related]
6. Myoclonic astatic epilepsy: an age-dependent epileptic syndrome with favorable seizure outcome but variable cognitive evolution. Trivisano M; Specchio N; Cappelletti S; Di Ciommo V; Claps D; Specchio LM; Vigevano F; Fusco L Epilepsy Res; 2011 Nov; 97(1-2):133-41. PubMed ID: 21873030 [TBL] [Abstract][Full Text] [Related]
7. Myoclonic status epilepticus following high-dosage lamotrigine therapy. Guerrini R; Belmonte A; Parmeggiani L; Perucca E Brain Dev; 1999 Sep; 21(6):420-4. PubMed ID: 10487478 [TBL] [Abstract][Full Text] [Related]
8. Lamotrigine can be beneficial in patients with Dravet syndrome. Dalic L; Mullen SA; Roulet Perez E; Scheffer I Dev Med Child Neurol; 2015 Feb; 57(2):200-2. PubMed ID: 25243660 [TBL] [Abstract][Full Text] [Related]
9. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience. Molina-Carballo A; Muñoz-Hoyos A; Reiter RJ; Sánchez-Forte M; Moreno-Madrid F; Rufo-Campos M; Molina-Font JA; Acuña-Castroviejo D J Pineal Res; 1997 Sep; 23(2):97-105. PubMed ID: 9392448 [TBL] [Abstract][Full Text] [Related]
10. Case of subacute sclerosing panencephalitis with atypical absences and myoclonic-atonic seizures as a first symptom. Dimova PS; Bojinova VS J Child Neurol; 2004 Jul; 19(7):548-52. PubMed ID: 15526962 [TBL] [Abstract][Full Text] [Related]
12. International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations. Tincani A; Brey R; Balestrieri G; Vitali C; Doria A; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S Clin Exp Rheumatol; 1996; 14 Suppl 16():S23-9. PubMed ID: 9049450 [TBL] [Abstract][Full Text] [Related]
14. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome]. Ampélas JF; Wattiaux MJ; Van Amerongen AP Encephale; 2001; 27(6):588-99. PubMed ID: 11865567 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of levetiracetam treatment in an epileptic patient with SLE. Siniscalchi A; Mancuso F; Gallelli L; Ferreri GI; Giovambattista DS Ann Pharmacother; 2005; 39(7-8):1367. PubMed ID: 15956229 [No Abstract] [Full Text] [Related]
16. A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus. Medlin JL; Hansen KE; Fitz SR; Bartels CM Semin Arthritis Rheum; 2016 Jun; 45(6):691-7. PubMed ID: 26972993 [TBL] [Abstract][Full Text] [Related]
17. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus. Fang H; Lan L; Qu Y; Zhang Q; Lv J J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196 [TBL] [Abstract][Full Text] [Related]